Skip to main content

ADVERTISEMENT

Rajesh M. Dave, MD, FACC, FSCAI

06/04/2012
A 49-year-old gentleman with histThe patient is a 46-year-old gentleman with no prior history of coronary artery disease who presented to the emergency room with six hours of chest pain and an electrocardiogram (EKG) consistent with acute...
A 49-year-old gentleman with histThe patient is a 46-year-old gentleman with no prior history of coronary artery disease who presented to the emergency room with six hours of chest pain and an electrocardiogram (EKG) consistent with acute...
A 49-year-old gentleman with...
06/04/2012
Cath Lab Digest
Case Report
11/05/2008
Utilization of laser ablation and intragraft glycoprotein IIb/IIIa inhibitors via ClearWay therapeutic infusion catheter to improve procedural safety We describe a complex thrombotic saphenous vein graft (SVG) percutaneous coronary...
Utilization of laser ablation and intragraft glycoprotein IIb/IIIa inhibitors via ClearWay therapeutic infusion catheter to improve procedural safety We describe a complex thrombotic saphenous vein graft (SVG) percutaneous coronary...
Utilization of laser ablation...
11/05/2008
Cath Lab Digest
05/02/2012
Case ReportA 49-year-old gentleman with history of hyperlipidemia presented to the emergency room with two hours of chest pain. His EKG demonstrated anterior wall ST-elevation myocardial infarction (STEMI). He was given aspirin 325 mg,...
Case ReportA 49-year-old gentleman with history of hyperlipidemia presented to the emergency room with two hours of chest pain. His EKG demonstrated anterior wall ST-elevation myocardial infarction (STEMI). He was given aspirin 325 mg,...
Case ReportA 49-year-old...
05/02/2012
Cath Lab Digest
Case Report
01/28/2009
Case 5 in a 5-part series Thrombus-containing lesions remain a clear and present danger for today’s interventionalists in the accomplishment of successful percutaneous coronary intervention (PCI) procedures. Sianos et al1 demonstrated that...
Case 5 in a 5-part series Thrombus-containing lesions remain a clear and present danger for today’s interventionalists in the accomplishment of successful percutaneous coronary intervention (PCI) procedures. Sianos et al1 demonstrated that...
Case 5 in a 5-part...
01/28/2009
Cath Lab Digest
12/22/2008
Using Pathway PV Jetstream or Laser Atherectomy, and Localized Delivery of Abciximab via ClearWay Rx Catheter Part 4 in a 5-part series In recent years, peripheral vascular intervention has seen significant growth with the advent of...
Using Pathway PV Jetstream or Laser Atherectomy, and Localized Delivery of Abciximab via ClearWay Rx Catheter Part 4 in a 5-part series In recent years, peripheral vascular intervention has seen significant growth with the advent of...
Using Pathway PV Jetstream or...
12/22/2008
Cath Lab Digest
STEMI Interventions
10/06/2008
Combining Mechanical Reperfusion and Pharmacologic Therapy to Improve Myocardial Perfusion Case 2 of 5: Continuation of STEMI Case Series from September 2008 Cath Lab Digest History of Present Illness A 57 year-old male was brought to the...
Combining Mechanical Reperfusion and Pharmacologic Therapy to Improve Myocardial Perfusion Case 2 of 5: Continuation of STEMI Case Series from September 2008 Cath Lab Digest History of Present Illness A 57 year-old male was brought to the...
Combining Mechanical Reperfusion...
10/06/2008
Cath Lab Digest
09/16/2008
Combining mechanical reperfusion and pharmacologic therapy to improve myocardial perfusion Primary percutaneous coronary intervention (PCI) to restore coronary blood flow is the current standard of care for ST-elevation myocardial infarction...
Combining mechanical reperfusion and pharmacologic therapy to improve myocardial perfusion Primary percutaneous coronary intervention (PCI) to restore coronary blood flow is the current standard of care for ST-elevation myocardial infarction...
Combining mechanical reperfusion...
09/16/2008
Cath Lab Digest
09/29/2017
/files/Abstract50Table.pngAbstracts from the Advanced Endovascular and Coronary Intervention Global Summit (C3) in June, 2017.
/files/Abstract50Table.pngAbstracts from the Advanced Endovascular and Coronary Intervention Global Summit (C3) in June, 2017.
...
09/29/2017
Journal of Invasive Cardiology
06/19/2008
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems...
06/19/2008
Cath Lab Digest
Case Report
07/02/2013
A 75-year-old patient who presented with acute left upper limb ischemia with rest pain, pallor, and partial paralysis was successfully treated with with a combined approach consisting of an embolic protection device, intralesion delivery of...
A 75-year-old patient who presented with acute left upper limb ischemia with rest pain, pallor, and partial paralysis was successfully treated with with a combined approach consisting of an embolic protection device, intralesion delivery of...
A 75-year-old patient who...
07/02/2013
Vascular Disease Management